US Patent

US9296782 — Inhibitors of hepatitis C virus

Composition of Matter · Assigned to Gilead Sciences Inc · Expires 2034-07-17 · 8y remaining

Vulnerability score 4/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent discloses compounds of Formula I and their pharmaceutically acceptable salts, as well as methods of using and pharmaceutical compositions containing them.

USPTO Abstract

Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number: US9296782
Jurisdiction: US
Classification: Composition of Matter
Expires: 2034-07-17
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.